NEW eLearning module for Myeloma now live
Dear BOPA members, The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…
Read article
SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment
Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…
Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)
Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…
Women for Oncology UK Spring Webinar
The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…
NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.
BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…
Toolkit for Immunotherapy IV to SC switch
Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…
Celebration of BOPA member’s recent publications
We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…
HSRPP workshop on conference abstracts
On behalf of the HSRPP Committee, Pharmacy Research UK are delighted to be hosting an online workshop on how to craft a good conference abstract. We will be covering points…
Helping Patients with Cancer in Primary Care: The patient journey
One of the Community Pharmacy Primary Care Subcommittee Members, Pete Robertson is producing a series videos for BOPA to help promote ways Community and Primary Care colleagues can support patients…
Abstract Submission for #BOPA2025 is NOW OPEN
Abstract Submission for the 28th Annual BOPA Conference 2025 is now OPEN Delegates are invited to present results of their clinical and technical work as a poster with some…
Share Your Insights – Global Thromboprophylaxis Practices in Cancer Care
Dear colleagues, We invite you to participate in a global survey on thromboprophylaxis practices for patients with cancer receiving ambulatory systemic therapies. This survey aims to understand current practices, assess…
HPCC/ KOL Haematology Research & Strategy Forum
We’re excited to share that BOPA has partnered with Sanius Health to facilitate and elevate this year’s Haematology Patients & Carers Congress (HPCC 2025), Europe’s first gathering of over 1,500+…